We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

Cambrex Manufacturing Facility Completes Successful US FDA Inspection

No Form 483 observations were issued.

BioLineRx Enters Clinic with Novel Treatment for Celiac Disease

Results of Phase 1/2 trial for BL-7010 expected in mid-2014.

Singapore: A Vibrant Hub for Biomedical Scientists

Ng Siew Kiang, Executive Director for Contact Singapore, discusses the growth of the biomedical sector in Singapore.

New Method for Determining Protein Structure has Major Implications for Drug Development

Ground-breaking discovery will improve the efficiency of protein structure determination, aiding targeted drug research.

Stem Cell Therapeutics Completes $33 Million Private Placement

Financing proceeds used to advance the Company’s CD47 cancer stem cell program.

BioLineRx Announces Promising Initial Phase 2 Results of AML Treatment

Initial results for BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis).

Umecrine Mood Announces Completion of Patient Recruitment

Patient recruitment in the phase I/II study of Umecrine Mood’s candidate drug for severe premenstrual symptoms.

FLUIDDA Presents Novel Imaging Technology for Respiratory Diseases to FDA

The FDA hearing is planned for January 17th in Washington DC.

3D Structure of Key Protein in Fight Against Homocystinuria Unveiled

The disease is caused by an increased plasma concentration of homocysteine, which is a toxic metabolite.

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

Networks will lead HIV/AIDS clinical trials research through 2021.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter